ALBINI EDWARD C

CIK 00012400142 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001240014

Recent Transactions

50 trades

Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-05-15−9,125→ 0 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-05-15+24,438→ 156,519 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-05-15$0.88/sh−15,995→ 160,805 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-05-15+9,125→ 176,800 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-05-15−24,438→ 27,312 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-05-15−11,156→ 4,594 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-05-15+11,156→ 167,675 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-05$1.36/sh−3,594→ 132,081 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-05+8,750→ 135,675 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-03-05−8,750→ 0 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-04+9,125→ 130,673 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-03-04−9,125→ 9,125 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-04$1.42/sh−3,748→ 126,925 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-03-01−7,875→ 15,750 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-01$1.59/sh−10,320→ 121,548 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-03-01−17,250→ 51,750 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-01+17,250→ 131,868 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-01+7,875→ 114,618 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (Right to Buy Common Stock)
2024-03-05+68,000→ 68,000 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2024-03-05−8,750→ 8,750 total
Award
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Units (RSUs)
2024-03-05+69,000→ 69,000 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-03-05$4.54/sh−3,100→ 106,743 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-03-05+8,750→ 109,843 total
Award
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Units (RSUs)
2024-03-05+51,000→ 51,000 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2024-03-04−9,125→ 18,250 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-03-04$4.79/sh−3,472→ 101,093 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-03-04+9,125→ 104,565 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-03-01+7,875→ 98,667 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2024-03-01−7,875→ 23,625 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-03-01$4.95/sh−3,227→ 95,440 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-01-29+5,250→ 92,943 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-01-29$4.99/sh−2,151→ 90,792 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2024-01-29−5,250→ 0 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2023-03-03+9,125→ 85,531 total
Award
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2023-03-03+31,500→ 31,500 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2023-03-03$5.79/sh−6,588→ 87,693 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2023-03-03−8,750→ 17,500 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2023-03-03−9,125→ 27,375 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy Common Stock)
2023-03-03+47,000→ 47,000 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2023-03-03+8,750→ 94,281 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2023-02-13−45,698→ 0 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2023-02-13$5.81/sh+45,698→ 76,406 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2023-01-27−5,250→ 5,250 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2023-01-27+5,250→ 32,848 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2023-01-27$7.50/sh−2,140→ 30,708 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2022-03-05+8,750→ 30,743 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2022-03-05$8.17/sh−3,145→ 27,598 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2022-03-05−8,750→ 26,250 total
Award
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2022-03-04+36,500→ 36,500 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy Common Stock)
2022-03-04+42,000→ 42,000 total

Companies

Recent Filings

Address

C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov